Today: 7 February 2026
Subscribe

Archer Aviation stock climbs nearly 4% as unusual call options pick up; Needham sticks with Buy

Archer Aviation stock climbs nearly 4% as unusual call options pick up; Needham sticks with Buy

Archer Aviation shares rose about 4% to $9.21 on Friday amid a surge in unusual call options activity and a reiterated Buy rating from Needham with a $10 target. Joby Aviation and Vertical Aerospace also posted gains. Archer’s “Midnight” eVTOL awaits further FAA approvals before commercial flights. The company’s next earnings report is expected around Feb. 26, according to MarketBeat.
16 January 2026
·
TSMC stock today: Blowout earnings meet a new U.S.-Taiwan trade deal — what happens next

TSMC stock today: Blowout earnings meet a new U.S.-Taiwan trade deal — what happens next

TSMC’s U.S.-listed shares rose 0.3% to $342.50 Friday after a 4.4% surge Thursday, driven by strong Q4 earnings and a new U.S.-Taiwan trade deal cutting chip tariffs. The company reported NT$505.74 billion in Q4 net income and expects up to $35.8 billion in Q1 revenue. TSMC pledged $100 billion U.S. investment for 2025 under the agreement. January sales figures are due Feb. 10.
16 January 2026
······
Vistra (VST) stock slides as White House PJM price-cap plan hits power producers

Vistra (VST) stock slides as White House PJM price-cap plan hits power producers

Vistra shares fell 6.8% to $167.91 Friday morning, leading declines among independent power producers after a report on possible PJM auction price caps. Constellation Energy dropped 9.6% and Talen Energy slid 9.0%. Governors in PJM states plan to sign a deal at the White House imposing two-year auction price caps and shifting more grid costs to data center operators, according to Reuters.
16 January 2026
···
Super Micro (SMCI) stock jumps on ‘dirt cheap’ valuation buzz even as margin fears linger

Super Micro (SMCI) stock jumps on ‘dirt cheap’ valuation buzz even as margin fears linger

Super Micro Computer shares rose about 6% in early trading Friday after bullish analyst notes, despite ongoing concerns over margins and execution. Goldman Sachs initiated coverage with a sell rating and a $26 target, while Mizuho cut its target to $31. Recent reports cite strong AI server demand but warn of margin pressures and negative free cash flow. Retail investor interest is rising, with YouTube commentary drawing tens of thousands of views.
16 January 2026
·
Walmart stock slips as CEO shake-up lands ahead of Nasdaq-100 entry

Walmart stock slips as CEO shake-up lands ahead of Nasdaq-100 entry

Walmart shares fell 0.3% to $118.82 after the company named David Guggina CEO of its U.S. business, with John Furner set to become overall CEO later this month. Chris Nicholas was appointed head of international, and Latriece Watkins will lead Sam’s Club U.S. Walmart joins the Nasdaq-100 on Jan. 20. Fourth-quarter earnings are scheduled for Feb. 19.
16 January 2026
·
Australia mortgage shock: CBA and Macquarie lift fixed home loan rates ahead of RBA decision

Australia mortgage shock: CBA and Macquarie lift fixed home loan rates ahead of RBA decision

Commonwealth Bank of Australia raised fixed home loan rates by up to 0.70 percentage points, with its three-year fixed rate now at 6.04%. Macquarie Bank also increased fixed rates, while NAB currently offers the lowest big-four fixed rate at 5.39%. The Reserve Bank of Australia meets Feb. 2–3, following a key inflation report due Jan. 28. The RBA cash rate remains at 3.6%.
16 January 2026
···
Salesforce stock slips again as AI “Cowork” jitters hit software names — what to watch next

Salesforce stock slips again as AI “Cowork” jitters hit software names — what to watch next

Salesforce shares fell 2% Friday to $228.57, underperforming the tech sector as investors worried that new AI agents could pressure subscription pricing. The decline weighed on the Dow, with Salesforce and UnitedHealth dragging the index lower. Analysts cited Anthropic’s product launches as a trigger for the sector’s selloff. Salesforce CEO Marc Benioff said AI tools have kept engineering headcount flat while boosting productivity.
16 January 2026
··
Denison Mines stock jumps with uranium names as Phoenix approvals come into focus

Denison Mines stock jumps with uranium names as Phoenix approvals come into focus

Denison Mines shares rose about 4.1% to $3.70 Friday morning, trading as high as $3.80, as uranium stocks advanced. Cameco gained 3.8% and Uranium Energy jumped 4.6%. Investors are watching for final approvals on Denison’s Phoenix uranium mine in Canada, which could start construction this year. Around 7.3 million Denison shares changed hands by mid-morning.
16 January 2026
·····
Intel stock slips from $50 high as Citi turns neutral and earnings near

Intel stock slips from $50 high as Citi turns neutral and earnings near

Intel shares fell 0.6% to $48.05 Friday morning, retreating from a $50.15 high, even as chip stocks broadly rallied. Citi, Barclays, RBC, and Loop Capital all raised price targets ahead of Intel’s earnings next week, citing foundry opportunities and advanced packaging shortages at TSMC. The iShares Semiconductor ETF rose 2.1%. Investors await Intel’s results amid heightened competition and new U.S.-Taiwan chip deals.
16 January 2026
··
AST SpaceMobile stock jumps on SHIELD contract slot, puts “Golden Dome” bids in focus

AST SpaceMobile stock jumps on SHIELD contract slot, puts “Golden Dome” bids in focus

AST SpaceMobile shares jumped 16% to $117.45 Friday after the company announced it won a prime spot on the Missile Defense Agency’s SHIELD contract vehicle. The SHIELD contract has a $151 billion ceiling but provides no upfront funding; payments depend on future task orders. Investors are watching for early orders and a company update. The Pentagon awarded 340 more SHIELD contracts Thursday, extending the deal through 2035.
16 January 2026
··
American Airlines stock slides as United rivalry at O’Hare sharpens — what to watch next

American Airlines stock slides as United rivalry at O’Hare sharpens — what to watch next

American Airlines shares fell 1.1% to $15.55 Friday morning, trailing rivals as investors watched a growing battle with United at Chicago O’Hare. United plans nearly 650 daily flights from the airport this summer, while American is adding about 100 peak-day flights. Gate access and pricing power remain in focus ahead of American’s Jan. 27 earnings report. Delta and Southwest shares were little changed.
16 January 2026
···
Rocket Lab stock jumps after Morgan Stanley upgrade as RKLB tests fresh highs

Rocket Lab stock jumps after Morgan Stanley upgrade as RKLB tests fresh highs

Rocket Lab shares rose 6.4% to $96.61 Friday after Morgan Stanley upgraded the stock and raised its price target to $105. The move followed a downgrade by KeyBanc a day earlier. Investors are watching for updates on the Neutron rocket timeline and the company’s next earnings report, expected near Feb. 26. Director Merline Saintil sold 108,500 shares this week, SEC filings show.
16 January 2026
···
Why ImmunityBio stock is surging today: ANKTIVA sales jump and a key bladder-cancer trial nears the finish line

Why ImmunityBio stock is surging today: ANKTIVA sales jump and a key bladder-cancer trial nears the finish line

ImmunityBio shares jumped 16.5% to $4.60 Friday after the company reported $113 million in preliminary 2025 net product revenue from ANKTIVA and disclosed accelerated approvals in Saudi Arabia for lung and bladder cancer uses. Trading volume topped 56 million shares. Enrollment in the company’s pivotal bladder-cancer trial surpassed 85%, with FDA filing planned by late 2026.
16 January 2026
···
Alphabet GOOG stock drops as AI copyright fight flares — what Wall Street watches next

Alphabet GOOG stock drops as AI copyright fight flares — what Wall Street watches next

Alphabet’s non-voting Class C shares fell about 1% to $330.00 in early Friday trading, underperforming the Nasdaq 100. The drop followed news that major book publishers joined a copyright lawsuit over Google’s AI training data and fresh concerns about limits to data-center expansion. A YouTube-BBC content deal could be announced next week. Alphabet’s earnings call is scheduled for February 4.
16 January 2026
···
Oracle stock price slips again as bondholder lawsuit keeps AI debt fears in play

Oracle stock price slips again as bondholder lawsuit keeps AI debt fears in play

Oracle shares fell about 1% Friday after a bondholder lawsuit alleged disclosure failures tied to debt raised for AI infrastructure linked to OpenAI. The case intensified concerns over rising borrowing by major tech firms, with credit markets uneasy about further debt issuance. Oracle executive Doug Kehring filed to sell 35,000 shares, valued at $6.82 million, on Thursday. U.S. markets close Monday for Martin Luther King Jr. Day.
16 January 2026
···
1 … 364 365 366 367 368 … 1,631

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop